Compile Data Set for Download or QSAR
Report error Found 71 Enz. Inhib. hit(s) with Target = 'Complement factor B [470-764]'
TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761323(US20250243186, Example 57)
Affinity DataKd:  0.170nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM732751((S)-4-(7-((5-cyclopropyl-7-methyl-1H-indol-4-yl)me...)
Affinity DataKd:  0.380nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761325(US20250243186, Example 47)
Affinity DataKd:  0.530nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761322(US20250243186, Example 43)
Affinity DataKd:  0.770nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761317(US20250243186, Example 40)
Affinity DataIC50: 1.80nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM732752(US20250115572, Ex-22 | US20250243186, Example 76)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761329(US20250243186, Example 79)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761330(US20250243186, Example 80)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761322(US20250243186, Example 43)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761332(US20250243186, Example 82)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761333(US20250243186, Example 62)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761323(US20250243186, Example 57)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761334(US20250243186, Example 83)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM732751((S)-4-(7-((5-cyclopropyl-7-methyl-1H-indol-4-yl)me...)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761325(US20250243186, Example 47)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761336(US20250243186, Example 85)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761326(US20250243186, Example 64)
Affinity DataIC50: 2nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761337(US20250243186, Example 86)
Affinity DataIC50: 2.10nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761316(CHEM-US-00368 4-(5-(difluoromethyl)-2-((5- methoxy...)
Affinity DataIC50: 2.60nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761317(US20250243186, Example 40)
Affinity DataIC50: 3nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761335(US20250243186, Example 84)
Affinity DataIC50: 3.10nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761321(CHEM-US-00371 4-(2-fluoro-7-((5-methoxy-7- methyl-...)
Affinity DataIC50: 4nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761307(US20250243186, Example 27)
Affinity DataKd:  4.25nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761315(US20250243186, Example 38)
Affinity DataIC50: 4.80nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761307(US20250243186, Example 27)
Affinity DataIC50: 5nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761307(US20250243186, Example 27)
Affinity DataIC50: 5.30nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761307(US20250243186, Example 27)
Affinity DataKd:  6.25nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761296(US20250243186, Example 8)
Affinity DataIC50: 7nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761309(CHEM-US-00311 4-(2-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataKd:  7.03nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761316(CHEM-US-00368 4-(5-(difluoromethyl)-2-((5- methoxy...)
Affinity DataIC50: 7.30nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761316(CHEM-US-00368 4-(5-(difluoromethyl)-2-((5- methoxy...)
Affinity DataIC50: 7.30nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761328(US20250243186, Example 78)
Affinity DataIC50: 7.40nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761309(CHEM-US-00311 4-(2-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataIC50: 7.5nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761312(CHEM-US-00320 4-((3aR,6aS)-2-((5-methoxy-7-methyl-...)
Affinity DataIC50: 7.70nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM160475(US9682968, Example-26a | US10093663, Example 26b |...)
Affinity DataKd:  9.93nMAssay Description:Table 2: Biacore 8 k instrument was primed using 1× PBS-P+ buffer before docking a Cytiva NTA chip. Recombinant human Factor B catalytic domain were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761313(CHEM-US-00323 4-(8-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataIC50: 16.6nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761299(US20250243186, Example 13)
Affinity DataIC50: 17.4nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761320(CHEM-US-00370 4-(2,2-difluoro-8-((5-methoxy- 7-met...)
Affinity DataIC50: 20.1nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761311(CHEM-US-00316 4-(2-((5-cyclopropyl-7-methyl-1H- in...)
Affinity DataIC50: 26.3nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761306(US20250243186, Example 26)
Affinity DataIC50: 31.5nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761297(US20250243186, Example 9)
Affinity DataIC50: 40.6nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761309(CHEM-US-00311 4-(2-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataIC50: 43.7nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761302(US20250243186, Example 22)
Affinity DataIC50: 45nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761331(US20250243186, Example 81)
Affinity DataIC50: 47.3nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761292(US20250243186, Example 2)
Affinity DataIC50: 60nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761292(US20250243186, Example 2)
Affinity DataIC50: 60nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761308(CHEM-US-00306 4-(7-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataIC50: 81.5nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761313(CHEM-US-00323 4-(8-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataIC50: 125nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761310(CHEM-US-00313 4-(2-((5-methoxy-7-methyl-1H-indol-4...)
Affinity DataIC50: 132nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

TargetComplement factor B [470-764](Human)
Hansoh Bio

US Patent
LigandPNGBDBM761294(US20250243186, Example 6)
Affinity DataIC50: 142nMAssay Description:Table 1: Factor B binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) tech...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent

Displayed 1 to 50 (of 71 total ) | Next | Last >>
Jump to: